Single-cell RNA-Sequencing (scRNA-Seq) has become the most widely used high-throughput method for transcription profiling of individual cells. Systematic errors, including batch effects, have been widely reported as a major challenge in high-throughput technologies. Surprisingly, these issues have received minimal attention in published studies based on scRNA-Seq technology. We examined data from all fifteen published studies including at least 200 samples and found that systematic errors can explain a substantial percentage of observed cell-to-cell expression variability. Specifically, we found that the proportion of genes reported as expressed explains a substantial part of observed variability and that this quantity varies systematically across experimental batches. Furthermore, we found that experimental designs that confound outcomes of interest with batch effects are common. Finally, we propose a simple experimental design that can ameliorate the effect of theses systematic errors have on downstream results.
Single-cell RNA-Sequencing (scRNA-Seq) has become the primary tool for profiling the transcriptomes of hundreds or even thousands of individual cells in parallel. Our experience with highthroughput genomic data in general, is that well thought-out data processing pipelines are essential to produce meaningful downstream results [1] [2] [3] . We expect the same to be true for scRNA-seq data. Here we show that while some tools developed for analyzing bulk RNA-Seq can be used for scRNA-Seq data, such as the mapping and alignment software, other steps in the processing, such as normalization, quality control and quantification, require new methods to account for the additional variability that is specific to this technology.
One of the most challenging sources of unwanted variability and systematic error in high-throughput data are what are commonly referred to as batch effects. Given the way that scRNA-Seq experiments are conducted, there is much room for concern regarding batch effects 4 . Specifically, batch effects occur when cells from one biological group or condition are cultured, captured and sequenced separate from cells in a second condition. Although batch information is not always included in the experimental annotations that are publicly available, one can extract surrogate variables from the raw sequencing (FASTQ) files 5 . Namely, the sequencing instrument used, the run number from the instrument and the flow cell lane. Although the sequencing is unlikely to be a major source of unwanted variability, it serves as a surrogate for other experimental procedures that very likely do have an effect, such as starting material, PCR amplification reagents/conditions, and cell cycle stage of the cells [6] [7] [8] . Here we will refer to the resulting differences induced by different groupings of these sources of variability as batch effects.
In a completely confounded study, it is not possible to determine if the biological condition or batch effects are driving the observed variation. In contrast, incorporating biological replicates across in the experimental design and processing the replicates across multiple batches permits observed variation to be attributed to biology or batch effects ( Figure 1 ). To demonstrate the widespread problem of systematic bias, batch effects, and confounded experimental designs in scRNA-Seq studies, we surveyed several published data sets. We discuss the consequences of failing to consider the presence of this unwanted technical variability, and consider new strategies to minimize its impact on scRNASeq data.
Batch and outcomes of interest are confounded in published scRNA-Seq experiments
We examined all publicly available scRNA-Seq data sets including at least 200 samples to investigate the extent of confounding biological variation with batch effects. These data sets were created using six different scRNA-Seq protocols for sequencing [9] [10] [11] [12] [13] [14] [15] and five studies include the use of unique molecular identifiers 16 (UMIs) for counting cDNA molecules. For each study, we downloaded the processed data available on GEO 17 and reconstructed the study design from the sequence identifiers provided in the FASTQ files. We used the standardized Pearson contingency coefficient to assess the experimental design between processing batches and outcome of interest and found values ranging from 82.1% to 100% (perfect confounding) in eight studies ( Table 1 ). Note that with this level of confounding it is nearly impossible to parse batch effects from biological variation. We could not assess the experimental design in the other seven studies because no biological outcomes of interest were defined, the purpose of the study was the discovery of novel cell types or the paper described a new technology. We note that in one of these studies for the discovery of novel cell types, the predicted cell type was provided and we found that the confounding percentage between the reported cell type and batch was 80.5% 18 .
cases in which the experimental design permitted this comparison (Tables S1-S6) , we found that batch explained more variability than biological group . We note that for three of the studies [20] [21] [22] we split the defined biological groups into subgroups because the differences between biological groups were pronounced, and we found similar results. In the two studies for which batch was completely confounded with biological group (Table S7 and S8) we also observed variability across batch ( Figure S8 ). However, in these cases it is impossible to separate variability due to biology or to batch. In seven of the studies, there were no biological outcomes of interest defined or the purpose of the study was for discovery of novel cell types (Figs S9-S15).
Batch effects lead to differences in detection rates, which lead to apparent differences between biological groups
To illustrate potential down stream effects, we examined 430 single-cells from five biological groups of interest for one of the studies in which at least one biological condition was split across two batches (Table S1 ). We confirmed that cells cluster by biological group ( Figure 3A) as reported in the original publication. However, four of the five biological groups were confounded with batch (Table S1 ) and batches can also explain the clustering ( Figure 3B ). The one group that was not confounded with batch confirms the high level of variability explained by processing cells in different batches ( Figure 3C ). As expected from the previous results, different batches lead to different proportions of detected genes ( Figure 3D ), which we have shown to be correlated with the first principal component and may be driving the observed biological variation across groups.
Detection rate has indirect effects on reported gene expression measurements
Using the processed scRNA-Seq data available on GEO, we computed the median of the non-zero measurements for each cell. For each study, we noticed a strong non-linear relationship between the median expression and the proportion of detected genes ( Figure 4 , Figure S16 ). We also found that the entire distribution of the non-zero genes changed with the proportion detected genes ( Figure S17 ).
The overall level of expression changing with the proportion of detected genes could be biologically driven, but there is a reasonable explanation of how it can be a technical artifact, which we explain using statistical notation. Let !" be the unobserved expression level for sample and gene . Let us consider only expressed genes ( !" > 0). In the sequencing experiment, each expressed gene has a probability of being amplified, which means we observe a quantity proportional to !" !" where protocol needed to run scRNA-Seq experiments imposed by the way cells are captured and sequenced in batches, standard balanced experimental designs are not possible 4, 25, 26 . An experimental design solution is to use biological replicates, namely independently repeating the experiment multiple times for each biological condition ( Figure 1 ). This approach allows for multiple batches of cells to be randomized across sequencing runs, flow cells and lanes as in bulk-RNA-Seq. With this design we can then model and adjust for batch effects due to systematic experimental bias. Other considerations for the design of a scRNA-Seq experiment such as the number of cells that should be generated can be determined using a power analysis, which will depend multiple factors including the goal of the study, the library complexity or sequencing depth required to detect most expressed genes, the protocol used to quantify the expression values such as using unique molecular identifiers 16 , and the success rate for failed single-cell libraries due to degraded RNA or low amplification efficiency. A more detailed discussion of how these factors affect the experimental design has been recently published 4, 26 .
Discussion
Batch effects and unwanted technical cell-to-cell noise remains a challenge in the analysis of scRNASeq data. The challenge is more complex than in previous sequencing experiments since experimental batches lead to different detection rates, which in turn lead to different transcription level estimates. In addition, detection of a gene or transcript in scRNA-Seq experiments is heavily dependent on the experimental protocol, which leads to systematic differences in the proportion of detected genes between batches of cells. The development of statistical methods that account for these systematic biases will therefore be essential in the analysis of scRNA-Seq data. Incorporating biological replicates in the experimental study design provides a solution to reducing confounding between biological condition and batch effects and will permit modeling of the technical variability that relates to processing the cells in different batches. The principal components were computed using the publicly available processed data available on GEO. The proportion of detected genes was calculated using the same processed data on GEO for all studies except for Patel et al. (2014) . In this case, because most non-detected genes were excluded from the publicly available processed data, we computed the proportion of detected genes from the raw data. Proportion of detected genes D
